BioCentury
ARTICLE | Clinical News

Alpha-tocopherol quinone: Preliminary Phase IIa data

June 20, 2011 7:00 AM UTC

Preliminary data from a double-blind, U.S. Phase IIa trial in 31 patients showed that once-daily 1 and 1.5 mg oral EPI-A0001 each missed the primary endpoint of significantly improving glucose disposi...